← Leaderboards
Ruslan Rafikov
University Of Arizona
$8,067,608
Attributed
$8,067,608
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,067,608 · 2
By mechanism
R01$8,067,608 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- Zhiyu Dai$7,862,593
- Ting Wang$4,535,149
- Rebekah L Mokry$143,364
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingCessation Of LifePathway InteractionsPulmonary HypertensionSignal TransductionPulmonary Arterial HypertensionCell ProliferationMitochondriaVascular RemodelingLungAttenuatedPathologicBindingCellsEndothelial CellsProteinsPeptidesPulmonary Artery StructureOxidative StressAntioxidantsAffinityHeart FailureHypoxiaEquilibrium
Grant awards (16)
Hemolysis and Free Heme Signaling in Pulmonary Hypertension$742,328
R01 · FY2025 · HL · contact PI
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension$653,701
R01 · FY2025 · HL · contact PI
Hemolysis and Free Heme Signaling in Pulmonary Hypertension$742,328
R01 · FY2024 · HL · contact PI
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension$655,252
R01 · FY2024 · HL · contact PI
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension$635,427
R01 · FY2023 · HL · contact PI
Hemolysis and free heme signaling in pulmonary hypertension$416,940
R01 · FY2023 · HL · contact PI
Hemolysis and free heme signaling in pulmonary hypertension$100,815
R01 · FY2023 · HL · contact PI
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension$648,802
R01 · FY2022 · HL · contact PI
Hemolysis and free heme signaling in pulmonary hypertension$517,755
R01 · FY2022 · HL · contact PI
Hemolysis and free heme signaling in pulmonary hypertension$517,755
R01 · FY2021 · HL · contact PI
Hemolysis and free heme signaling in pulmonary hypertension$517,755
R01 · FY2020 · HL · contact PI
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.$383,750
R01 · FY2020 · HL · contact PI
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.$383,750
R01 · FY2019 · HL · contact PI
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.$383,750
R01 · FY2018 · HL · contact PI
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.$383,750
R01 · FY2017 · HL · contact PI
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.$383,750
R01 · FY2016 · HL · contact PI